GlaxoSmithKline Pharma Wins!
Ambassador Cain and AmCham Executive Director Stephen Brugger with GSK Managing Director Julie Edwards.
There are 13 photos in this gallery.
Click the image above to see the additional pictures
GlaxoSmithKline Pharma A/S (GSK) has won the 2008 Foreign Company of the Year Award from the American Chamber of Commerce in Denmark.
“We are honored to accept this award,” said GSK Managing Director Julie Edwards. She pointed out that GSK invests significantly in research in universities and hospitals in Denmark, and looks forward to a continued strong local engagement.
The annual AmCham award highlights the significance of foreign direct investment in Denmark, and recognizes the contributions, importance and positive impact made by foreign companies operating in this country. The award’s independent jury panel consists of Toms Gruppen CEO Jesper Møller, Director Henning Dyremose, and Copenhagen Business School Professor Steen Thomsen.
Significant is right – there are about 3,000 foreign companies in Denmark, employing 235,000 workers directly and more indirectly, Executive Director Stephen Brugger said.
Edwards accepted the award at a reception at Rydhave, the official residence of U.S. Ambassador James Cain. Ambassador Cain, the jury panel, and Brugger joined Edwards, other GSK executives, and representatives of many Danish and foreign companies at the event, which was sponsored by Ford and Continental.
What A Winner!
Dyremose, who is chairman of the Danish Trade Council, said that GSK’s collaborations with Danish companies and municipalities have boosted competitiveness. Simultaneously, GSK has contributed to and learned from Denmark’s competence cluster of biotech and medical companies. The panel cited GSK’s significant investment in research and development projects in Denmark, GSK’s openness and transparency, as well as its production of life-saving medicines that benefits many Danes.
“What a winner! What a winner that really contributes to building up knowledge and creating growth in Danish society,” Dyremose said.
Edwards accepted the award to hearty applause. Guests mingled and networked at the reception, an anticipated and enjoyable AmCham gathering each year.
GSK joins an impressive list: AmCham’s previous Foreign Company award winners have been iMotions (2007), CSC and Topsoe Fuel Cell (2006), Texas Instruments Denmark (2005), and Nypro Denmark (2004).
Opportunities and Challenges
Edwards took the opportunity to point out that opportunities and challenges remain for foreign companies in Denmark. She said some things in particular will be critical to the continued success of such companies in cooperation with the Danish government. It will take a commitment to Danish society, more foreign investment, and good corporate citizenship. It will take a collaborative effort to address Denmark’s labor shortage. It will also take a lot of hard work.
This year’s award comes as AmCham Denmark prepares for its Foreign Investors Summit, scheduled for Thursday, October 23 in Hellerup. The summit will examine the challenges facing foreign companies here, and what it will take to get foreign companies to continue to invest in Denmark.